Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A large-scale study involving over 2,400 patients with type 2 diabetes found that the majority of participants who began GLP-1 agonist treatment experienced weight loss over a 72-week period
Get personalized guidance from a clinician or RD
The tissue is forgiving, you can see what you are doing without contorting, and there is enough real estate to run a full week of daily injections without repeating a spot
Clinical trials suggest that, on average, by week 12, a weight loss of at least 5% of the starting body weight is typically achievable
Why weight comes back Weight regain is not a willpower failure
The Bigger Concern: Leaving a Deficiency Untreated When weighing the minimal risks of B12 injections, it helps to consider the well-documented risks of an untreated B12 deficiency
